These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21478148)

  • 1. Identification of a novel Bcl-2-interacting mediator of cell death (Bim) E3 ligase, tripartite motif-containing protein 2 (TRIM2), and its role in rapid ischemic tolerance-induced neuroprotection.
    Thompson S; Pearson AN; Ashley MD; Jessick V; Murphy BM; Gafken P; Henshall DC; Morris KT; Simon RP; Meller R
    J Biol Chem; 2011 Jun; 286(22):19331-9. PubMed ID: 21478148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid degradation of Bim by the ubiquitin-proteasome pathway mediates short-term ischemic tolerance in cultured neurons.
    Meller R; Cameron JA; Torrey DJ; Clayton CE; Ordonez AN; Henshall DC; Minami M; Schindler CK; Saugstad JA; Simon RP
    J Biol Chem; 2006 Mar; 281(11):7429-36. PubMed ID: 16431916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Cbl is not required for ERK1/2-dependent degradation of BimEL.
    Wiggins CM; Band H; Cook SJ
    Cell Signal; 2007 Dec; 19(12):2605-11. PubMed ID: 17884340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BIM(EL), an intrinsically disordered protein, is degraded by 20S proteasomes in the absence of poly-ubiquitylation.
    Wiggins CM; Tsvetkov P; Johnson M; Joyce CL; Lamb CA; Bryant NJ; Komander D; Shaul Y; Cook SJ
    J Cell Sci; 2011 Mar; 124(Pt 6):969-77. PubMed ID: 21378313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer cells with the BRAF(V600E) mutation are addicted to the ERK1/2 pathway for growth factor-independent survival and repression of BIM.
    Wickenden JA; Jin H; Johnson M; Gillings AS; Newson C; Austin M; Chell SD; Balmanno K; Pritchard CA; Cook SJ
    Oncogene; 2008 Dec; 27(57):7150-61. PubMed ID: 18806830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining the minimal sequence required for ERK1/2-dependent poly-ubiquitination and proteasome-dependent turnover of BIM.
    Wiggins CM; Johnson M; Cook SJ
    Cell Signal; 2010 May; 22(5):801-8. PubMed ID: 20074640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and Role of TRIM2 in Human Diseases.
    Xiao M; Li J; Liu Q; He X; Yang Z; Wang D
    Biomed Res Int; 2022; 2022():9430509. PubMed ID: 36051486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDK1, not ERK1/2 or ERK5, is required for mitotic phosphorylation of BIMEL.
    Gilley R; Lochhead PA; Balmanno K; Oxley D; Clark J; Cook SJ
    Cell Signal; 2012 Jan; 24(1):170-80. PubMed ID: 21924351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function.
    Qi XJ; Wildey GM; Howe PH
    J Biol Chem; 2006 Jan; 281(2):813-23. PubMed ID: 16282323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid ischemic tolerance induced by adenosine preconditioning results in Bcl-2 interacting mediator of cell death (Bim) degradation by the proteasome.
    Ordonez AN; Jessick VJ; Clayton CE; Ashley MD; Thompson SJ; Simon RP; Meller R
    Int J Physiol Pathophysiol Pharmacol; 2010; 2(1):36-44. PubMed ID: 20957068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin-induced phosphorylation/degradation of BIM contributes to survival of erythroid cells.
    Abutin RM; Chen J; Lung TK; Lloyd JA; Sawyer ST; Harada H
    Exp Hematol; 2009 Feb; 37(2):151-8. PubMed ID: 19100675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
    Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
    Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interplay of TRIM2 E3 Ubiquitin Ligase and ALIX/ESCRT Complex: Control of Developmental Plasticity During Early Neurogenesis.
    Lokapally A; Neuhaus H; Herfurth J; Hollemann T
    Cells; 2020 Jul; 9(7):. PubMed ID: 32698497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multisite phosphorylation regulates Bim stability and apoptotic activity.
    Hübner A; Barrett T; Flavell RA; Davis RJ
    Mol Cell; 2008 May; 30(4):415-25. PubMed ID: 18498746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEK/ERK-mediated phosphorylation of Bim is required to ensure survival of T and B lymphocytes during mitogenic stimulation.
    O'Reilly LA; Kruse EA; Puthalakath H; Kelly PN; Kaufmann T; Huang DC; Strasser A
    J Immunol; 2009 Jul; 183(1):261-9. PubMed ID: 19542438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylarsine oxide induces apoptosis in Bax- and Bak-deficient cells through upregulation of Bim.
    Ni B; Ma Q; Li B; Zhao L; Liu Y; Zhu Y; Chen Q
    Clin Cancer Res; 2012 Jan; 18(1):140-51. PubMed ID: 22048238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of Bim and Erk-mediated Bim(EL) phosphorylation are dispensable for hematopoietic homeostasis in vivo.
    Clybouw C; Merino D; Nebl T; Masson F; Robati M; O'Reilly L; Hübner A; Davis RJ; Strasser A; Bouillet P
    Cell Death Differ; 2012 Jun; 19(6):1060-8. PubMed ID: 22240894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM2, a novel member of the antiviral family, limits New World arenavirus entry.
    Sarute N; Ibrahim N; Medegan Fagla B; Lavanya M; Cuevas C; Stavrou S; Otkiran-Clare G; Tyynismaa H; Henao-Mejia J; Ross SR
    PLoS Biol; 2019 Feb; 17(2):e3000137. PubMed ID: 30726215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BimEL is phosphorylated at mitosis by Aurora A and targeted for degradation by βTrCP1.
    Moustafa-Kamal M; Gamache I; Lu Y; Li S; Teodoro JG
    Cell Death Differ; 2013 Oct; 20(10):1393-403. PubMed ID: 23912711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR-dependent downregulation of Bim in epithelial cells requires MAPK and PKC-delta activities.
    Quadros MR; Connelly S; Kari C; Abrams MT; Wickstrom E; Rodeck U
    Cancer Biol Ther; 2006 May; 5(5):498-504. PubMed ID: 16582597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.